Literature DB >> 21214718

Physical exercise with weight reduction lowers blood pressure and improves abnormal left ventricular relaxation in pharmacologically treated hypertensive patients.

Giuseppe Cocco1, Stefano Pandolfi.   

Abstract

In spite of appropriate pharmacologic therapy, many hypertensive patients develop an abnormal left ventricular relaxation with preserved systolic function. This cardiac dysfunction increases the risk of cardiovascular complications. The authors assessed the therapeutic effects of an intervention with exercise training and weight reduction in patients with pharmacologically well-treated hypertension who had abnormal left ventricular relaxation with normal systolic function. Eighty-eight (44%) of 202 medically treated hypertensive patients had abnormal ventricular relaxation with normal ejection fraction. These patients were randomized to either a 6-month intervention program (cycle ergometer training twice a day for 5 days a week and a hypocaloric diet) or a control program (unchanged pharmacologic therapy without exercise and diet. Body weight, blood pressure, New York Heart Association class, glomerular filtration rate, and exercise capacity and workload were measured. Cardiac function was assessed by measuring N-terminal pro-B-type natriuretic peptide values, the electrocardiographic QT dispersion interval, and echocardiography (left atrial size, Doppler-derived E/A ratio, and mitral deceleration time). Physical exercise with weight reduction reduced blood pressure, decreased cardiovascular risks, and improved abnormal left ventricular relaxation. Measuring left atrial size is the best method for assessing changes in left ventricular relaxation with preserved systolic function.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21214718      PMCID: PMC8673266          DOI: 10.1111/j.1751-7176.2010.00380.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  31 in total

Review 1.  Measurement, interpretation and clinical potential of QT dispersion.

Authors:  M Malik; V N Batchvarov
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  How to diagnose diastolic heart failure a consensus statement.

Authors:  Liv Hatle
Journal:  Eur Heart J       Date:  2007-09-21       Impact factor: 29.983

4.  Heart failure with preserved ejection fraction: dangerous, elusive, and difficult.

Authors:  Olav W Nielsen; Lars Køber; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2008-01-17       Impact factor: 29.983

5.  QT dispersion: still a useful measurement.

Authors:  Janos Molnar; John C Somberg
Journal:  Cardiology       Date:  2008-07-24       Impact factor: 1.869

6.  Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size.

Authors:  D Reed; R D Abbott; M L Smucker; S Kaul
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

7.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

8.  Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.

Authors:  Andrew S P Sharp; Robyn J Tapp; Simon A McG Thom; Darrel P Francis; Alun D Hughes; Alice V Stanton; Andrew Zambanini; Eoin O'Brien; Nish Chaturvedi; Simon Lyons; Sheila Byrd; Neil R Poulter; Peter S Sever; Jamil Mayet
Journal:  Eur Heart J       Date:  2009-11-26       Impact factor: 29.983

9.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 10.  Kidney function during exercise in healthy and diseased humans. An update.

Authors:  J R Poortmans; J Vanderstraeten
Journal:  Sports Med       Date:  1994-12       Impact factor: 11.136

View more
  5 in total

Review 1.  Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature.

Authors:  M L Fitzgibbon; L M Tussing-Humphreys; J S Porter; I K Martin; A Odoms-Young; L K Sharp
Journal:  Obes Rev       Date:  2011-11-10       Impact factor: 9.213

Review 2.  Physical activity for the prevention and treatment of metabolic disorders.

Authors:  Luca Montesi; Simona Moscatiello; Marcella Malavolti; Rebecca Marzocchi; Giulio Marchesini
Journal:  Intern Emerg Med       Date:  2013-05-09       Impact factor: 3.397

Review 3.  Lack of exercise is a major cause of chronic diseases.

Authors:  Frank W Booth; Christian K Roberts; Matthew J Laye
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

4.  Prevalence, risk factors, and management of prehypertension.

Authors:  Wenwen Zhang; Ninghua Li
Journal:  Int J Hypertens       Date:  2011-10-29       Impact factor: 2.420

5.  Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function.

Authors:  Giuseppe Cocco; Paul Jerie
Journal:  Clin Pract       Date:  2013-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.